fda glp-1 compounding warning october 2025 unleashes letters to firms selling compounded GLP-1s FDA Moves to Permanently Close

Still, researchers with active malignancy are generally advised to avoid telomerase-activating compounds until more definitive safety data becomes available

Mechanisms of cancer cachexia

While exercise enthusiasts may be motivated by appearance and physique, everyone should be interested in retaining muscle mass as a means of preserving long term health

A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo

For a closer look at the antioxidant side, see our cross-cluster guide to glutathione IV therapy while being clear that raising glutathione is supportive, not a stand-alone treatment for confirmed toxicity

"The lack of acknowledgement that obesity is a disease has been damaging to people for generations